Anoro Ellipta is a combination of two bronchodilators in a single dry powder inhaler, the Ellipta. It includes umeclidinium (UMEC), a long-acting muscarinic antagonist (LAMA) and vilanterol (VI),
The objective of the Elaris EMIII and Elaris EMIV extension studies was to assess the long-term safety and efficacy of elagolix for the management of endometriosis with associated pain..
In 1984, the partnership had formed Kirin-Amgen to fund the global development of Epogen (epoetin alfa). Later, Kirin-Amgen also involved in the development of Neupogen, Neulasta (pegfilgrastim), Aranesp
The merger will result in a combined company, Vaxart, Inc., focused on developing orally-delivered therapeutics and prophylactics to address a variety of viral infections. “We are thrilled with
MCL represents 3% to 10% of all non-Hodgkin lymphoma cases in the US, as per the National Cancer Institute at the National Institutes of Health. Calquence functions by
The transaction is expected to help Novartis with near-term product launches along with the addition of a new technology platform with potential applications in various oncology early development
The company has revealed positive top-line results from three pivotal phase 3 clinical trials assessing risankizumab compared to ustekinumab and adalimumab to treat patients with moderate to severe
The company did not reveal the exact reason behind the withdrawal of the Marketing Authorisation Application (MAA) of the Keytruda combination. However, the company's move is due to an
Synthon is the partner of the US-based Mylan for the development and supply of its Glatiramer Acetate Injection 40mg/mL product across Europe. The 3-times-a-week injection is the substitutable
The new investment at the Limerick Industrial Operations and Product Supply (IOPS) campus will create an additional 300 new jobs. Regeneron has taken its total investment for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.